December 23, 2023
The Genetic Aberrations Underlying Melanocytic Tum...
Medical Student Award – Summer Meyer
March 31, 2026
Press Release
5 Minute Read
FEATURED | May 1, 2026
Jason Chambers Teams Up with the Melanoma Researc...
Superyacht Captain, Star of Bravo’s “Below Deck Down Under” and Melanoma Advocate Urges All to Embrace Healthy Sun-Safe Behaviors and #GetNaked…It May Save Your...
1 Minute Read
December 23, 2023
Understanding the Role of Peroxisomes in Regulatin...
Medical Student Award – Stephanie Mills
December 23, 2023
Mechanisms of Macrophage Evasion in Residual Melan...
Medical Student Award – Jude Raj
December 23, 2023
Defining the dynamics of ICOS+ CD4 T cell response...
Medical Student Award – Megen Wittling
December 23, 2023
Targeting the eIF4F, Translation Initiation Comple...
The translation initiation complex (or TIC) is one of the last unexplored targets in cancer therapy or melanoma. Protein production is tightly controlled by a complex of fo...
December 19, 2023
NKT infiltration and rejection in melanomas
Current immunotherapies have dramatically improved clinical outcomes, but more than half of metastatic melanoma patients have poor responses and primary resistance. With ti...
December 19, 2023
TGFßi NK Cell Infusions in Patients with Melanoma...
Brain metastases remain a leading cause of death in patients with metastatic melanoma. One of the most exciting advances in the treatment of CNS metastases was combined che...
December 19, 2023
Targeting an adaptor function of CDK6 to enhance m...
Immunotherapy has been remarkably successful in the treatment of melanoma, but not all patients benefit from therapy and its effects is in most cases temporary, followed by...
December 19, 2023
Immunogenic landscape and therapeutic targeting of...
Many cancer immunotherapy patients fail to respond or progress after initially experiencing tumor regression. More than 25% of melanomas carry activating mutations in the d...
December 19, 2023
Targeting melanoma with engineered CD4+ T cells
Both helper CD4 T cells and killer CD8 T cells are known to be involved in immune responses to cancer. Helper CD4 T cells assist immune responses to cancer by enhancing the...
December 19, 2023
Deciphering the role of APRIL/TNFSF13 in melanoma-...
The overall survival of a subset of patients with melanoma drastically improved with a type of treatment called immunotherapy, which activates the body’s immune system to...
December 19, 2023
Evaluation of cutaneous immune related adverse eve...
The treatment of melanoma with checkpoint inhibitor (CPI) therapy has produced rapid and substantial gains in survival, and as a result, the indications for its use have st...
Events & Fundraisers
May 26, 2026 ET
Ask the Expert: Understanding Melanoma Risk: How Prognostic Testing Can Help Guide Your Care
